Syngeneic and semi-syngeneic transplantation resistance

Syngeneic and semi-syngeneic transplantation resistance refers to the set of immunologic barriers that can prevent successful engraftment even when donor and recipient are genetically identical or nearly so. In syngeneic transplants—such as those between identical twins—the main risks include graft failure due to residual host immunity if pre-conditioning is insufficient, absence of beneficial graft-versus-tumor effects leading to higher relapse rates in cancer patients, and possible development of autoimmune complications if regulatory lymphocyte populations are disrupted. The underlying biology involves complex interactions among various immune subsets including regulatory T cells and natural killer cells rather than any single druggable protein or receptor.

Other names

Syngeneic graft rejectionSemi-syngeneic transplant resistanceHost-versus-graft response in syngeneic settings

Not applicable as there is no single molecular entity targeted; however: Immunosuppressants suppress host immune responses that mediate rejection. Cytokines like IL-2 can enhance anti-tumor immunity via NK cells in syngeneic models. Conditioning regimens deplete host immune components that cause graft rejection/failure.